1
|
Chen Y, Jiang H, Sun Z, Liu F, Su M. Hydantoin derivative dimers as broad-spectrum antimicrobial agents against ESKAPE pathogens with enhanced killing rate and stability. RSC Med Chem 2024; 15:2340-2350. [PMID: 39026634 PMCID: PMC11253853 DOI: 10.1039/d4md00374h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2024] [Accepted: 05/29/2024] [Indexed: 07/20/2024] Open
Abstract
A new series of hydantoin derivative dimers as potential broad-spectrum antibiotic agents is designed and synthesized to combat ESKAPE pathogens. As membrane-active antimicrobial agents, in addition to cationic charged and hydrophobic groups that mimic AMPs (antimicrobial peptides), hydantoin backbones and aromatic linkers increased the rigidity and lipophilicity of the designed compounds, thus improving the stability and bactericidal killing rate. After whole cell phenotypic screening against eight bacterial strains, including MRSA (methicillin-resistant S. aureus), compound 18 was chosen as the lead compound with overall excellent broad-spectrum antibacterial activity (GM = 7.32 μg mL-1) and good selectivity. Kill-kinetic studies of compound 18 showed that the bacterial growth of both Gram-positive and Gram-negative was completely inhibited within one hour, which demonstrated excellent sterilization efficiency of 18. Furthermore, drug resistance and mechanism studies showed that compound 18 exhibited a steady antibacterial performance during 25 passages and could disrupt bacterial cell membrane integrity and cause cell death. Along with the facile synthesis procedures in solution, this series of hydantoin derivative dimer compounds could be an appealing next generation of antibiotic agents to combat emergent drug resistance.
Collapse
Affiliation(s)
- Yating Chen
- Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 China
- Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 People's Republic of China
| | - Huiqin Jiang
- Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 China
- Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 People's Republic of China
| | - Zibin Sun
- Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 China
- Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 People's Republic of China
| | - Feng Liu
- Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 China
- Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 People's Republic of China
| | - Ma Su
- Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Medicinal Chemistry, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 China
- Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, College of Pharmaceutical Sciences, Soochow University 199 Ren-Ai Road Suzhou Jiangsu 215123 People's Republic of China
| |
Collapse
|
2
|
Lyra KM, Tournis I, Subrati M, Spyrou K, Papavasiliou A, Athanasekou C, Papageorgiou S, Sakellis E, Karakassides MA, Sideratou Z. Carbon Nanodisks Decorated with Guanidinylated Hyperbranched Polyethyleneimine Derivatives as Efficient Antibacterial Agents. NANOMATERIALS (BASEL, SWITZERLAND) 2024; 14:677. [PMID: 38668171 PMCID: PMC11054016 DOI: 10.3390/nano14080677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/20/2024] [Revised: 04/08/2024] [Accepted: 04/09/2024] [Indexed: 04/29/2024]
Abstract
Non-toxic carbon-based hybrid nanomaterials based on carbon nanodisks were synthesized and assessed as novel antibacterial agents. Specifically, acid-treated carbon nanodisks (oxCNDs), as a safe alternative material to graphene oxide, interacted through covalent and non-covalent bonding with guanidinylated hyperbranched polyethyleneimine derivatives (GPEI5K and GPEI25K), affording the oxCNDs@GPEI5K and oxCNDs@GPEI25K hybrids. Their physico-chemical characterization confirmed the successful and homogenous attachment of GPEIs on the surface of oxCNDs, which, due to the presence of guanidinium groups, offered them improved aqueous stability. Moreover, the antibacterial activity of oxCNDs@GPEIs was evaluated against Gram-negative E. coli and Gram-positive S. aureus bacteria. It was found that both hybrids exhibited enhanced antibacterial activity, with oxCNDs@GPEI5K being more active than oxCNDs@GPEI25K. Their MIC and MBC values were found to be much lower than those of oxCNDs, revealing that the GPEI attachment endowed the hybrids with enhanced antibacterial properties. These improved properties were attributed to the polycationic character of the oxCNDs@GPEIs, which enables effective interaction with the bacterial cytoplasmic membrane and cell walls, leading to cell envelope damage, and eventually cell lysis. Finally, oxCNDs@GPEIs showed minimal cytotoxicity on mammalian cells, indicating that these hybrid nanomaterials have great potential to be used as safe and efficient antibacterial agents.
Collapse
Affiliation(s)
- Kyriaki-Marina Lyra
- Institute of Nanoscience and Nanotechnology, National Center for Scientific Reasearch “Demokritos”, Aghia Paraskevi, 15310 Athens, Greece; (K.-M.L.); (I.T.); (M.S.); (A.P.); (C.A.); (S.P.); or (E.S.)
| | - Ioannis Tournis
- Institute of Nanoscience and Nanotechnology, National Center for Scientific Reasearch “Demokritos”, Aghia Paraskevi, 15310 Athens, Greece; (K.-M.L.); (I.T.); (M.S.); (A.P.); (C.A.); (S.P.); or (E.S.)
| | - Mohammed Subrati
- Institute of Nanoscience and Nanotechnology, National Center for Scientific Reasearch “Demokritos”, Aghia Paraskevi, 15310 Athens, Greece; (K.-M.L.); (I.T.); (M.S.); (A.P.); (C.A.); (S.P.); or (E.S.)
| | - Konstantinos Spyrou
- Department of Material Science & Engineering, University of Ioannina, 45110 Ioannina, Greece; (K.S.); (M.A.K.)
| | - Aggeliki Papavasiliou
- Institute of Nanoscience and Nanotechnology, National Center for Scientific Reasearch “Demokritos”, Aghia Paraskevi, 15310 Athens, Greece; (K.-M.L.); (I.T.); (M.S.); (A.P.); (C.A.); (S.P.); or (E.S.)
| | - Chrysoula Athanasekou
- Institute of Nanoscience and Nanotechnology, National Center for Scientific Reasearch “Demokritos”, Aghia Paraskevi, 15310 Athens, Greece; (K.-M.L.); (I.T.); (M.S.); (A.P.); (C.A.); (S.P.); or (E.S.)
| | - Sergios Papageorgiou
- Institute of Nanoscience and Nanotechnology, National Center for Scientific Reasearch “Demokritos”, Aghia Paraskevi, 15310 Athens, Greece; (K.-M.L.); (I.T.); (M.S.); (A.P.); (C.A.); (S.P.); or (E.S.)
| | - Elias Sakellis
- Institute of Nanoscience and Nanotechnology, National Center for Scientific Reasearch “Demokritos”, Aghia Paraskevi, 15310 Athens, Greece; (K.-M.L.); (I.T.); (M.S.); (A.P.); (C.A.); (S.P.); or (E.S.)
- Physics Department, Condensed Matter Physics Section, National and Kapodistrian University of Athens, Panepistimiopolis, Zografos, 15784 Athens, Greece
| | - Michael A. Karakassides
- Department of Material Science & Engineering, University of Ioannina, 45110 Ioannina, Greece; (K.S.); (M.A.K.)
| | - Zili Sideratou
- Institute of Nanoscience and Nanotechnology, National Center for Scientific Reasearch “Demokritos”, Aghia Paraskevi, 15310 Athens, Greece; (K.-M.L.); (I.T.); (M.S.); (A.P.); (C.A.); (S.P.); or (E.S.)
| |
Collapse
|
3
|
Hernando-Gozalo M, Aguilera-Correa JJ, Rescalvo-Casas C, Seijas-Pereda L, García-Bertolín C, de la Mata FJ, Sánchez-Nieves J, Cuadros J, Pérez-Tanoira R. Study of the antimicrobial activity of cationic carbosilane dendrimers against clinical strains of multidrug-resistant bacteria and their biofilms. Front Cell Infect Microbiol 2023; 13:1203991. [PMID: 37886663 PMCID: PMC10598583 DOI: 10.3389/fcimb.2023.1203991] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2023] [Accepted: 09/20/2023] [Indexed: 10/28/2023] Open
Abstract
Introduction Antimicrobial Resistance is a serious public health problem, which is aggravated by the ability of the microorganisms to form biofilms. Therefore, new therapeutic strategies need to be found, one of them being the use of cationic dendritic systems (dendrimers and dendrons). Methods The aim of this study is to analyze the in vitro antimicrobial efficacy of six cationic carbosilane (CBS) dendrimers and one dendron with peripheral ammonium groups against multidrug-resistant bacteria, some of them isolated hospital strains, and their biofilms. For this purpose, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), minimum biofilm inhibitory concentration (MBIC) and minimum eradication biofilm concentration (MBEC) studies were carried out. In addition, the cytotoxicity on Hela cells of those compounds that proved to be the most effective was analyzed. Results All the tested compounds showed in vitro activity against the planktonic forms of methicillin-resistant Staphylococcus aureus and only the dendrimers BDSQ017, BDAC-001 and BDLS-001 and the dendron BDEF-130 against their biofilms. On the other hand, only the dendrimers BDAC 001, BDLS-001 and BDJS-049 and the dendron BDEF-130 were antibacterial in vitro against the planktonic forms of multidrug-resistant Pseudomonas aeruginosa, but they lacked activity against their preformed biofilms. In addition, the dendrimers BDAC-001, BDLS-001 and BDSQ-017 and the dendron BDEF-130 exhibited a good profile of cytotoxicity in vitro. Discussion Our study demonstrates the possibility of using the four compounds mentioned above as possible topical antimicrobials against the clinical and reference strains of multidrug-resistant bacteria.
Collapse
Affiliation(s)
- Marcos Hernando-Gozalo
- University of Alcalá, Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. del Río” (IQAR), Madrid, Spain
| | - John Jairo Aguilera-Correa
- Clinical Microbiology Department, Instituto de Investigación Sanitaria (IIS)-Fundacion Jimenez Diaz-Universidad Autónoma de Madrid (UAM), Madrid, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
| | - Carlos Rescalvo-Casas
- University of Alcalá, Department of Biomedicine and Biotechnology, Faculty of Medicine, Madrid, Spain
| | - Laura Seijas-Pereda
- University of Alcalá, Department of Biomedicine and Biotechnology, Faculty of Medicine, Madrid, Spain
- Clinical Microbiology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
| | - Carlos García-Bertolín
- Clinical Microbiology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
| | - Francisco Javier de la Mata
- University of Alcalá, Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. del Río” (IQAR), Madrid, Spain
- Ramón y Cajal Institute for Health Research, Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain
| | - Javier Sánchez-Nieves
- University of Alcalá, Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. del Río” (IQAR), Madrid, Spain
- Ramón y Cajal Institute for Health Research, Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain
| | - Juan Cuadros
- University of Alcalá, Department of Biomedicine and Biotechnology, Faculty of Medicine, Madrid, Spain
- Clinical Microbiology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
| | - Ramón Pérez-Tanoira
- University of Alcalá, Department of Biomedicine and Biotechnology, Faculty of Medicine, Madrid, Spain
- Clinical Microbiology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
| |
Collapse
|
4
|
Galanakou C, Dhumal D, Peng L. Amphiphilic dendrimers against antibiotic resistance: light at the end of the tunnel? Biomater Sci 2023; 11:3379-3393. [PMID: 36866708 DOI: 10.1039/d2bm01878k] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
With the alarming and prevailing antimicrobial resistance (AMR) comes an urgent need for novel antimicrobial agents that are not only effective and robust but also do not induce resistance development. Amphiphilic dendrimers are emerging as a promising new paradigm to combat bacterial AMR. They can mimic antimicrobial peptides to produce potent antibacterial activity yet with a low likelihood of generating resistance. In addition, they are stable against enzymatic degradation thanks to their unique dendritic architecture. Importantly, these amphiphilic dendrimers are composed of distinct hydrophobic and hydrophilic entities bearing dendritic structures, which can be precisely designed and synthesized to optimize the hydrophobic-hydrophilic balance yielding potent antibacterial activity while minimizing adverse effects and drug resistance. In this short review, we present the challenges and current state of research in developing amphiphilic dendrimers as new antibiotic substitutes. We start with a brief overview of the advantages and opportunities associated with using amphiphilic dendrimers to combat bacterial AMR. We then outline the specific considerations and the mechanisms underlying the antibacterial activity of amphiphilic dendrimers. We focus on the importance of the amphiphilic nature of a dendrimer that balances hydrophobicity and hydrophilicity via gauging the hydrophobic entity and the dendrimer generation, branching unit, terminal group and charge to allow high antibacterial potency and selectivity while minimizing toxicity. Finally, we present the future challenges and perspectives for amphiphilic dendrimers as antibacterial candidates for combating AMR.
Collapse
Affiliation(s)
- Christina Galanakou
- Centre Interdisciplinaire de Nanoscience de Marseille, CINaM, UMR 7325, Aix Marseille University, CNRS, Parc Scientifique et Technologique de Luminy, Marseille, 13288, France.
| | - Dinesh Dhumal
- Centre Interdisciplinaire de Nanoscience de Marseille, CINaM, UMR 7325, Aix Marseille University, CNRS, Parc Scientifique et Technologique de Luminy, Marseille, 13288, France.
| | - Ling Peng
- Centre Interdisciplinaire de Nanoscience de Marseille, CINaM, UMR 7325, Aix Marseille University, CNRS, Parc Scientifique et Technologique de Luminy, Marseille, 13288, France.
| |
Collapse
|
5
|
Sarkar B, Mahapa A, Dey K, Manhas R, Chatterji D, Jayaraman N. Aza-Michael promoted glycoconjugation of PETIM dendrimers and selectivity in mycobacterial growth inhibitions. RSC Adv 2023; 13:4669-4677. [PMID: 36760308 PMCID: PMC9897202 DOI: 10.1039/d2ra08196b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Accepted: 01/25/2023] [Indexed: 02/05/2023] Open
Abstract
The benign nature of aza-Michael addition reaction in aqueous solutions is demonstrated herein to conduct a direct glycoconjugation of amine-terminated poly(ether imine) (PETIM) dendrimers. Zero to three generations of dendrimers, possessing up to 16 amine functionalities at their peripheries, undergo aza-Michael reaction with unsaturated sugar vinyl sulfoxide in aq. MeOH solutions and afford the corresponding dendrimers modified with multiple glycosyl moieties at the periphery. First order kinetics of the glycoconjugation is monitored at varying temperatures and the rate constants are observed to be 60-508 s-1, for zero and first generation dendrimers. The antibacterial effects of amine-terminated dendrimers and the corresponding glycoconjugates are studied across Gram-positive, Gram-negative and acid-fast bacteria. Among the species, M. smegmatis and M. tuberculosis showed the greatest growth inhibition effect at micromolar concentrations, for the native amine-terminated and the corresponding glycoconjugated dendrimers. Quantitative assays are performed to adjudge the inhibition efficacies of dendrimers and the glycoconjugates. Selectivity to inhibit M. smegmatis and M. tuberculosis growth, and minimal effects on other bacterial species by dendrimers and glycoconjugates are emphasized.
Collapse
Affiliation(s)
- Biswajit Sarkar
- Department of Organic Chemistry, Indian Institute of Science Bangalore 560 012 India
| | - Avisek Mahapa
- Molecular Biophysics Unit, Indian Institute of Science Bangalore 560 012 India
- Infectious Disease Department, CSIR-Indian Institute of Integrative Medicine Jammu-180001 India
| | - Kalyan Dey
- Department of Organic Chemistry, Indian Institute of Science Bangalore 560 012 India
| | - Rakshit Manhas
- Infectious Disease Department, CSIR-Indian Institute of Integrative Medicine Jammu-180001 India
| | - Dipankar Chatterji
- Molecular Biophysics Unit, Indian Institute of Science Bangalore 560 012 India
| | | |
Collapse
|
6
|
Popp PF, Lozano-Cruz T, Dürr F, Londaitsbehere A, Hartig J, de la Mata FJ, Gómez R, Mascher T, Revilla-Guarinos A. The Novel Synthetic Antibiotic BDTL049 Based on a Dendritic System Induces Lipid Domain Formation while Escaping the Cell Envelope Stress Resistance Determinants. Pharmaceutics 2023; 15:297. [PMID: 36678925 PMCID: PMC9866484 DOI: 10.3390/pharmaceutics15010297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Revised: 01/10/2023] [Accepted: 01/11/2023] [Indexed: 01/17/2023] Open
Abstract
The threat of antimicrobial-resistant bacteria is ever increasing and over the past-decades development of novel therapeutic counter measurements have virtually come to a halt. This circumstance calls for interdisciplinary approaches to design, evaluate and validate the mode of action of novel antibacterial compounds. Hereby, carbosilane dendritic systems that exhibit antimicrobial properties have the potential to serve as synthetic and rationally designed molecules for therapeutic use. The bow-tie type topology of BDTL049 was recently investigated against the Gram-positive model organism Bacillus subtilis, revealing strong bactericidal properties. In this study, we follow up on open questions concerning the usability of BDTL049. For this, we synthesized a fluorescent-labeled version of BDTL049 that maintained all antimicrobial features to unravel the interaction of the compound and bacterial membrane. Subsequently, we highlight the bacterial sensitivity against BDTL049 by performing a mutational study of known resistance determinants. Finally, we address the cytotoxicity of the compound in human cells, unexpectedly revealing a high sensitivity of the eukaryotic cells upon BDTL049 exposure. The insights presented here further elaborate on the unique features of BDTL049 as a promising candidate as an antimicrobial agent while not precluding that further rounds of rational designing are needed to decrease cytotoxicity to ultimately pave the way for synthetic antibiotics toward clinical applicability.
Collapse
Affiliation(s)
- Philipp F. Popp
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, 01217 Dresden, Germany
| | - Tania Lozano-Cruz
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. Del Río” (IQAR), University de Alcalá, 28805 Madrid, Spain
- Ramón y Cajal Health Research Institute (IRYCIS), 28805 Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28805 Madrid, Spain
| | - Franziska Dürr
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, 01217 Dresden, Germany
| | - Addis Londaitsbehere
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. Del Río” (IQAR), University de Alcalá, 28805 Madrid, Spain
| | - Johanna Hartig
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, 01217 Dresden, Germany
| | - Francisco Javier de la Mata
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. Del Río” (IQAR), University de Alcalá, 28805 Madrid, Spain
- Ramón y Cajal Health Research Institute (IRYCIS), 28805 Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28805 Madrid, Spain
| | - Rafael Gómez
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. Del Río” (IQAR), University de Alcalá, 28805 Madrid, Spain
- Ramón y Cajal Health Research Institute (IRYCIS), 28805 Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28805 Madrid, Spain
| | - Thorsten Mascher
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, 01217 Dresden, Germany
| | - Ainhoa Revilla-Guarinos
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, 01217 Dresden, Germany
| |
Collapse
|
7
|
Immobilization of Alcalase on Silica Supports Modified with Carbosilane and PAMAM Dendrimers. Int J Mol Sci 2022; 23:ijms232416102. [PMID: 36555742 PMCID: PMC9783553 DOI: 10.3390/ijms232416102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2022] [Revised: 12/13/2022] [Accepted: 12/14/2022] [Indexed: 12/23/2022] Open
Abstract
Enzyme immobilization is a powerful strategy for enzyme stabilization and recyclability. Materials covered with multipoint molecules are very attractive for this goal, since the number of active moieties to attach the enzyme increases with respect to monofunctional linkers. This work evaluates different dendrimers supported on silica to immobilize a protease enzyme, Alcalase. Five different dendrimers were employed: two carbosilane (CBS) dendrimers of different generations (SiO2-G0Si-NH2 and SiO2-G1Si-NH2), a CBS dendrimer with a polyphenoxo core (SiO2-G1O3-NH2), and two commercial polyamidoamine (PAMAM) dendrimers of different generations (SiO2-G0PAMAM-NH2 and SiO2-G1PAMAM-NH2). The results were compared with a silica support modified with a monofunctional molecule (2-aminoethanethiol). The effect of the dendrimer generation, the immobilization conditions (immobilization time, Alcalase/SiO2 ratio, and presence of Ca2+ ions), and the digestion conditions (temperature, time, amount of support, and stirring speed) on Alcalase activity has been evaluated. Enzyme immobilization and its activity were highly affected by the kind of dendrimer and its generation, observing the most favorable behavior with SiO2-G0PAMAM-NH2. The enzyme immobilized on this support was used in two consecutive digestions and, unlike CBS supports, it did not retain peptides released in the digestion.
Collapse
|
8
|
de la Mata FJ, Gómez R, Cano J, Sánchez‐Nieves J, Ortega P, Gallego SG. Carbosilane dendritic nanostructures, highly versatile platforms for pharmaceutical applications. WIRES NANOMEDICINE AND NANOBIOTECHNOLOGY 2022; 15:e1871. [PMID: 36417901 DOI: 10.1002/wnan.1871] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2022] [Revised: 10/21/2022] [Accepted: 10/23/2022] [Indexed: 11/25/2022]
Abstract
Dendrimers are multifunctional molecules with well-defined size and structure due to the step-by-step synthetic procedures required in their preparation. Dendritic constructs based on carbosilane scaffolds present carbon-carbon and carbon-silicon bonds, which results in stable, lipophilic, inert, and flexible structures. These properties are highly appreciated in different areas, including the pharmaceutical field, as they can increase the interaction with cell membranes and improve the therapeutic action. This article summarizes the most recent advances in the pharmaceutical applications of carbosilane dendritic molecules, from therapeutics to diagnostics and prevention tools. Dendrimers decorated with cationic, anionic, or other moieties, including metallodendrimers; supramolecular assemblies; dendronized nanoparticles and surfaces; as well as dendritic networks like hydrogels are described. The collected examples confirm the potential of carbosilane dendrimers and dendritic materials as antiviral or antibacterial agents; in therapy against cancer, neurodegenerative disease, or oxidative stress; or many other biomedical applications. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.
Collapse
Affiliation(s)
- Francisco Javier de la Mata
- Department of Organic and Inorganic Chemistry, Faculty of Sciences, and Research Institute in Chemistry “Andrés M. del Río” (IQAR) Universidad de Alcala Alcalá de Henares Spain
- CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III
- Institute Ramón y Cajal for Health Research (IRYCIS) Madrid Spain
| | - Rafael Gómez
- Department of Organic and Inorganic Chemistry, Faculty of Sciences, and Research Institute in Chemistry “Andrés M. del Río” (IQAR) Universidad de Alcala Alcalá de Henares Spain
- CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III
- Institute Ramón y Cajal for Health Research (IRYCIS) Madrid Spain
| | - Jesús Cano
- Department of Organic and Inorganic Chemistry, Faculty of Sciences, and Research Institute in Chemistry “Andrés M. del Río” (IQAR) Universidad de Alcala Alcalá de Henares Spain
- CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III
- Institute Ramón y Cajal for Health Research (IRYCIS) Madrid Spain
| | - Javier Sánchez‐Nieves
- Department of Organic and Inorganic Chemistry, Faculty of Sciences, and Research Institute in Chemistry “Andrés M. del Río” (IQAR) Universidad de Alcala Alcalá de Henares Spain
- CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III
- Institute Ramón y Cajal for Health Research (IRYCIS) Madrid Spain
| | - Paula Ortega
- Department of Organic and Inorganic Chemistry, Faculty of Sciences, and Research Institute in Chemistry “Andrés M. del Río” (IQAR) Universidad de Alcala Alcalá de Henares Spain
- CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III
- Institute Ramón y Cajal for Health Research (IRYCIS) Madrid Spain
| | - Sandra García Gallego
- Department of Organic and Inorganic Chemistry, Faculty of Sciences, and Research Institute in Chemistry “Andrés M. del Río” (IQAR) Universidad de Alcala Alcalá de Henares Spain
- CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III
- Institute Ramón y Cajal for Health Research (IRYCIS) Madrid Spain
| |
Collapse
|
9
|
López-Barona P, Verdú-Expósito C, Martín-Pérez T, Gómez-Casanova N, Lozano-Cruz T, Ortega P, Gómez R, Pérez-Serrano J, Heredero-Bermejo I. Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts. Sci Rep 2022; 12:14926. [PMID: 36056060 PMCID: PMC9440212 DOI: 10.1038/s41598-022-19200-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Accepted: 08/25/2022] [Indexed: 11/18/2022] Open
Abstract
Amoebae from the genus Acanthamoeba are important pathogens responsible for severe illnesses in humans such as Acanthamoeba keratitis and granulomatous amoebic encephalitis. In the last few decades, AK diagnoses have steadily increased. Most patients suffering from AK were contact lens users and the infection was related to poor hygiene. However, therapy is not yet well established, and treatments may last for several months due to resistance. Moreover, these treatments have been described to generate cytotoxicity. Therefore, there is an urgent need to develop new therapeutic strategies against AK. In this study, the amoebicidal activity of different generation cationic carbosilane dendrons derived with 4-phenylbutyric acid was demonstrated against Acanthamoeba polyphaga and Acanthamoeba griffini trophozoites and cysts. In addition, the combination of chlorhexidine digluconate and the most effective dendron (ArCO2G2(SNMe3I)4) showed an in vitro effect against Acanthamoeba trophozoites and cysts, reducing the minimal trophozoite amoebicidal concentration as well as concentrations with cysticidal activity.
Collapse
Affiliation(s)
- P López-Barona
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871, Alcalá de Henares, Spain
| | - C Verdú-Expósito
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871, Alcalá de Henares, Spain
| | - T Martín-Pérez
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871, Alcalá de Henares, Spain
| | - N Gómez-Casanova
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871, Alcalá de Henares, Spain
| | - T Lozano-Cruz
- Department of Organic and Inorganic Chemistry, Andrés M. del Río Chemistry Research Institute (IQAR), Ramón y Cajal Health Research Institute (IRYCIS), Bioengineering, Biomaterials and Nanomedicine Networking Research Center (CIBER-BBN), University of Alcalá, 28871, Madrid, Spain
| | - P Ortega
- Department of Organic and Inorganic Chemistry, Andrés M. del Río Chemistry Research Institute (IQAR), Ramón y Cajal Health Research Institute (IRYCIS), Bioengineering, Biomaterials and Nanomedicine Networking Research Center (CIBER-BBN), University of Alcalá, 28871, Madrid, Spain
| | - R Gómez
- Department of Organic and Inorganic Chemistry, Andrés M. del Río Chemistry Research Institute (IQAR), Ramón y Cajal Health Research Institute (IRYCIS), Bioengineering, Biomaterials and Nanomedicine Networking Research Center (CIBER-BBN), University of Alcalá, 28871, Madrid, Spain
| | - J Pérez-Serrano
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871, Alcalá de Henares, Spain
| | - I Heredero-Bermejo
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871, Alcalá de Henares, Spain.
| |
Collapse
|
10
|
Revilla-Guarinos A, Popp PF, Dürr F, Lozano-Cruz T, Hartig J, de la Mata FJ, Gómez R, Mascher T. Synthesis and mechanism-of-action of a novel synthetic antibiotic based on a dendritic system with bow-tie topology. Front Microbiol 2022; 13:912536. [PMID: 36090105 PMCID: PMC9459136 DOI: 10.3389/fmicb.2022.912536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2022] [Accepted: 07/26/2022] [Indexed: 12/05/2022] Open
Abstract
Over the course of the last decades, the continuous exposure of bacteria to antibiotics-at least in parts due to misprescription, misuse, and misdosing-has led to the widespread development of antimicrobial resistances. This development poses a threat to the available medication in losing their effectiveness in treating bacterial infections. On the drug development side, only minor advances have been made to bring forward novel therapeutics. In addition to increasing the efforts and approaches of tapping the natural sources of new antibiotics, synthetic approaches to developing novel antimicrobials are being pursued. In this study, BDTL049 was rationally designed using knowledge based on the properties of natural antibiotics. BDTL049 is a carbosilane dendritic system with bow-tie type topology, which has antimicrobial activity at concentrations comparable to clinically established natural antibiotics. In this report, we describe its mechanism of action on the Gram-positive model organism Bacillus subtilis. Exposure to BDTL049 resulted in a complex transcriptional response, which pointed toward disturbance of the cell envelope homeostasis accompanied by disruption of other central cellular processes of bacterial metabolism as the primary targets of BDTL049 treatment. By applying a combination of whole-cell biosensors, molecular staining, and voltage sensitive dyes, we demonstrate that the mode of action of BDTL049 comprises membrane depolarization concomitant with pore formation. As a result, this new molecule kills Gram-positive bacteria within minutes. Since BDTL049 attacks bacterial cells at different targets simultaneously, this might decrease the chances for the development of bacterial resistances, thereby making it a promising candidate for a future antimicrobial agent.
Collapse
Affiliation(s)
- Ainhoa Revilla-Guarinos
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, Dresden, Germany
| | - Philipp F. Popp
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, Dresden, Germany
| | - Franziska Dürr
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, Dresden, Germany
| | - Tania Lozano-Cruz
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. Del Río” (IQAR), University de Alcalá, Madrid, Spain
- Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain
| | - Johanna Hartig
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, Dresden, Germany
| | - Francisco Javier de la Mata
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. Del Río” (IQAR), University de Alcalá, Madrid, Spain
- Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain
| | - Rafael Gómez
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. Del Río” (IQAR), University de Alcalá, Madrid, Spain
- Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain
| | - Thorsten Mascher
- Department of General Microbiology, Institut Für Mikrobiologie, Technische Universität Dresden, Dresden, Germany
| |
Collapse
|
11
|
Synthesis of Carbosilane and Carbosilane-Siloxane Dendrons Based on Limonene. Polymers (Basel) 2022; 14:polym14163279. [PMID: 36015536 PMCID: PMC9416742 DOI: 10.3390/polym14163279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2022] [Revised: 08/09/2022] [Accepted: 08/10/2022] [Indexed: 11/16/2022] Open
Abstract
In this work, carbosilane dendrons of the first, second, and third generations were obtained on the basis of a natural terpenoid, limonene. Previously, we have shown the possibility of selective hydrosilylation and hydrothiolation of limonene. It is proved that during hydrosilylation, only the isoprenyl double bond reacts, while the cyclohexene double bond does not undergo into the hydrosilylation reaction. However, the cyclohexene double bond reacts by hydrothiolation. This selectivity makes it possible to use limonene as a dendron growth center, while maintaining a useful function—a double bond at the focal point. Thus, the sequence of hydrosilylation and Grignard reactions based on limonene formed carbosilane dendrons. After that, the end groups were blocked by heptamethyltrisiloxane or butyllithium. The obtained substances were characterized using NMR spectroscopy, elemental analysis and GPC. Thus, the proposed methodology for the synthesis of carbosilane dendrons based on the natural terpenoid limonene opens up wide possibilities for obtaining various macromolecules: dendrimers, Janus dendrimers, dendronized polymers, and macroinitiators.
Collapse
|
12
|
Quintana-Sánchez S, Barrios-Gumiel A, Sánchez-Nieves J, Copa-Patiño JL, de la Mata FJ, Gómez R. Bacteria capture with magnetic nanoparticles modified with cationic carbosilane dendritic systems. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2021; 133:112622. [PMID: 35525744 DOI: 10.1016/j.msec.2021.112622] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Revised: 11/12/2021] [Accepted: 12/15/2021] [Indexed: 12/19/2022]
Abstract
Bacteria elimination from water sources is key to obtain drinkable water. Hence, the design of systems with ability to interact with bacteria and remove them from water is an attractive proposal. A diversity of polycationic macromolecules has shown bactericide properties, due to interactions with bacteria membranes. In this work, we have grafted cationic carbosilane (CBS) dendrons and dendrimers on the surface of iron oxide magnetic nanoparticles (MNP), leading to NP (ca. 10 nm) that interact with bacteria by covering bacteria membrane. Application of an external magnetic field removes MNP from solution sweeping bacteria attached to them. The interaction of the MNP with Gram-positive S. aureus bacteria is more sensible to the size of dendritic system covering the MNP, whereas interaction with Gram-negative E. coli bacteria is more sensible to the density of cationic groups. Over 500 ppm of NPM, MNP covered with dendrons captured over 90% of both type of bacteria, whereas MNP covered with dendrimers were only able to capture S. aureus bacteria (over 90%) but not E. coli bacteria. Modified MNP were characterized by transmission electron microscopy (TEM), thermogravimetric analysis (TGA), Fourier-transform infrared spectroscopy (FTIR), Z potential and dynamic light scattering (DLS). Interaction with bacteria was analyzed by UV, TEM and scanning electron microscopy (SEM). Moreover, the possibility to recycle cationic dendronized MNP was explored.
Collapse
Affiliation(s)
- Sara Quintana-Sánchez
- Dpto. de Química Orgánica y Química Inorgánica, Universidad de Alcalá (UAH); Instituto de Investigación Química "Andrés M. del Río" (IQAR), Universidad de Alcalá (UAH); Alcalá de Henares (Madrid), Spain; Networking Research Center for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, Madrid, Spain
| | - Andrea Barrios-Gumiel
- Dpto. de Química Orgánica y Química Inorgánica, Universidad de Alcalá (UAH); Instituto de Investigación Química "Andrés M. del Río" (IQAR), Universidad de Alcalá (UAH); Alcalá de Henares (Madrid), Spain; Networking Research Center for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, Madrid, Spain
| | - Javier Sánchez-Nieves
- Dpto. de Química Orgánica y Química Inorgánica, Universidad de Alcalá (UAH); Instituto de Investigación Química "Andrés M. del Río" (IQAR), Universidad de Alcalá (UAH); Alcalá de Henares (Madrid), Spain; Networking Research Center for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, Madrid, Spain.
| | - José L Copa-Patiño
- Dpto. de Biomedicina y Biotecnología, Universidad de Alcalá (UAH), Alcalá de Henares (Madrid), Spain
| | - F Javier de la Mata
- Dpto. de Química Orgánica y Química Inorgánica, Universidad de Alcalá (UAH); Instituto de Investigación Química "Andrés M. del Río" (IQAR), Universidad de Alcalá (UAH); Alcalá de Henares (Madrid), Spain; Networking Research Center for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, Madrid, Spain.
| | - Rafael Gómez
- Dpto. de Química Orgánica y Química Inorgánica, Universidad de Alcalá (UAH); Instituto de Investigación Química "Andrés M. del Río" (IQAR), Universidad de Alcalá (UAH); Alcalá de Henares (Madrid), Spain; Networking Research Center for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, Madrid, Spain
| |
Collapse
|
13
|
Eradication of Candida albicans Biofilm Viability: In Vitro Combination Therapy of Cationic Carbosilane Dendrons Derived from 4-Phenylbutyric Acid with AgNO 3 and EDTA. J Fungi (Basel) 2021; 7:jof7070574. [PMID: 34356953 PMCID: PMC8305162 DOI: 10.3390/jof7070574] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Revised: 07/13/2021] [Accepted: 07/15/2021] [Indexed: 01/18/2023] Open
Abstract
Candida albicans is a human pathogen of significant clinical relevance. This pathogen is resistant to different drugs, and most clinical antifungals are not effective against the prevention and treatment of C. albicans infections. As with other microorganisms, it can produce biofilms that serve as a barrier against antifungal agents and other substances, contributing to infection in humans and environmental tolerance of this microorganism. Thus, resistances and biofilm formation make treatment difficult. In addition, the complete eradication of biofilms in implants, catheters and other medical devices, is challenging and necessary to prevent relapses of candidemia. Therefore, it is a priority to find new molecules or combinations of compounds with anti-Candida biofilm activity. Due to the difficulty of treating and removing biofilms, the aim of this study was to evaluate the in vitro ability of different generation of cationic carbosilane dendrons derived from 4-phenylbutyric acid, ArCO2Gn(SNMe3I)m, to eradicate C. albicans biofilms. Here, we assessed the antifungal activity of the second generation dendron ArCO2G2(SNMe3I)4 against C. albicans cells and established biofilms since it managed to seriously damage the membrane. In addition, the combinations of the second generation dendron with AgNO3 or EDTA eradicated the viability of biofilm cells. Alterations were observed by scanning electron microscopy and cytotoxicity was assessed on HeLa cells. Our data suggest that the dendritic compound ArCO2G2(SNMe3I)4 could represent an alternative to control the infections caused by this pathogen.
Collapse
|
14
|
Martín-Pérez T, Heredero-Bermejo I, Verdú-Expósito C, Pérez-Serrano J. In Vitro Evaluation of the Combination of Melaleuca alternifolia (Tea Tree) Oil and Dimethyl Sulfoxide (DMSO) against Trophozoites and Cysts of Acanthamoeba Strains. Oxygen Consumption Rate (OCR) Assay as a Method for Drug Screening. Pathogens 2021; 10:pathogens10040491. [PMID: 33921633 PMCID: PMC8073477 DOI: 10.3390/pathogens10040491] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2021] [Revised: 03/31/2021] [Accepted: 04/14/2021] [Indexed: 11/16/2022] Open
Abstract
Ameobae belonging to the genus Acanthamoeba are responsible for the human diseases Acanthamoeba keratitis (AK) and granulomatous amoebic encephalitis (GAE). The treatment of these illnesses is hampered by the existence of a resistance stage (cysts). In an attempt to add new agents that are effective against trophozoites and cysts, tea tree oil (TTO) and dimethyl sulfoxide (DMSO), separately and in combination, were tested In Vitro against two Acanthamoeba isolates, T3 and T4 genotypes. The oxygen consumption rate (OCR) assay was used as a drug screening method, which is to some extent useful in amoebicide drug screening; however, evaluation of lethal effects may be misleading when testing products that promote encystment. Trophozoite viability analysis showed that the effectiveness of the combination of both compounds is higher than when either compound is used alone. Therefore, the TTO alone or TTO + DMSO in combination were an amoebicide, but most of the amoebicidal activity in the combination’s treatments seemed to be caused mainly by the TTO effect. In fact, DMSO alone seems to be a non-amoebicide, triggering encystment. Regarding cytotoxicity, these compounds showed toxicity in human corneal epithelial cells (HCEpiC), even at low concentrations when tested in combination. In conclusion, the use of TTO and DMSO, in combination or alone, cannot be recommended as an alternative for AK treatment until more cytotoxicity and cyst adhesion tests are performed.
Collapse
|
15
|
Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells. Antioxidants (Basel) 2020; 9:antiox9100993. [PMID: 33066634 PMCID: PMC7602517 DOI: 10.3390/antiox9100993] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Accepted: 10/08/2020] [Indexed: 02/07/2023] Open
Abstract
The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is considered as the master regulator of antioxidant and cytoprotective gene expressions. Moreover, it plays a pivotal role in cancer progression. Nrf2 mediates the adaptive response which contributes to the resistance to chemotherapeutic pro-oxidant drugs, such as cisplatin (CDDP), in various tumors, including bladder cancers. For this reason, Nrf2 could be a promising target to overcome chemoresistance. There are several known Nrf2 pharmacological inhibitors; however, most of them are not specific. The use of a specific small interfering RNA (siRNA) targeting the Nrf2 gene (siNrf2) loaded into nanovehicles is an attractive alternative, since it can increase specificity. This study aimed to evaluate the biological activity of siNrf2 loaded on guanidine-terminated carbosilane dendrimers (GCDs) in overcoming CDDP resistance in bladder cancer cells with a high level of Nrf2. Parameters such as viability, proliferation, apoptosis, migration, and oxidative stress level were taken into account. Results demonstrated that siNrf2-GCD treatment sensitized CDDP-resistant cells to CDDP treatment. Moreover, data obtained by treating the non-cancerous human kidney HK-2 cell line strongly suggest a good safety profile of the carbosilane dendrimers loaded with siNrf2. In conclusion, we suggest that siNrf2-GCD is a promising drug delivery system for gene therapy to be used in vivo; and it may represent an important tool in the therapy of CDDP-resistant cancer.
Collapse
|
16
|
Heredero-Bermejo I, Gómez-Casanova N, Quintana S, Soliveri J, de la Mata FJ, Pérez-Serrano J, Sánchez-Nieves J, Copa-Patiño JL. In Vitro Activity of Carbosilane Cationic Dendritic Molecules on Prevention and Treatment of Candida Albicans Biofilms. Pharmaceutics 2020; 12:E918. [PMID: 32992733 PMCID: PMC7601597 DOI: 10.3390/pharmaceutics12100918] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2020] [Revised: 09/17/2020] [Accepted: 09/21/2020] [Indexed: 12/28/2022] Open
Abstract
Candida spp. are one of the most common fungal pathogens. Biofilms formed by Candidaalbicans offer resistance mechanisms against most antifungal agents. Therefore, development of new molecules effective against these microorganisms, alone or in combination with antifungal drugs, is extremely necessary. In the present work, we carried out a screening process of different cationic carbosilane dendritic molecules against C. albicans. In vitro activity against biofilm formation and biofilms was tested in both Colección Española de Cultivos Tipo (CECT) 1002 and clinical C. albicans strains. Cytotoxicity was studied in human cell lines, and biofilm alterations were observed by scanning electron microscopy (SEM). Antifungal activity of the carbosilane dendritic molecules was assessed by monitoring cell viability using both established and novel cell viability assays. One out of 14 dendritic molecules tested, named BDSQ024, showed the highest activity with a minimum biofilm inhibitory concentration (MBIC) for biofilm formation and a minimum biofilm damaging concentration (MBDC) for existing biofilm of 16-32 and 16 mg/L, respectively. Synergy with amphotericin (AmB) and caspofungin (CSF) at non-cytotoxic concentrations was found. Therefore, dendritic compounds are exciting new antifungals effective at preventing Candida biofilm formation and represent a potential novel therapeutic agent for treatment of C. albicans infection in combination with existing clinical antifungals.
Collapse
Affiliation(s)
- Irene Heredero-Bermejo
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, Spain; (N.G.-C.); (J.S.); (J.P.-S.); (J.L.C.-P.)
| | - Natalia Gómez-Casanova
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, Spain; (N.G.-C.); (J.S.); (J.P.-S.); (J.L.C.-P.)
| | - Sara Quintana
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. del Río” (IQAR), University of Alcalá, 28871 Alcalá de Henares, Spain; (S.Q.); (F.J.d.l.M.); (J.S.-N.)
- Institute “Ramón y Cajal” for Health Research (IRYCIS), 28034 Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029 Madrid, Spain
| | - Juan Soliveri
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, Spain; (N.G.-C.); (J.S.); (J.P.-S.); (J.L.C.-P.)
| | - Francisco Javier de la Mata
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. del Río” (IQAR), University of Alcalá, 28871 Alcalá de Henares, Spain; (S.Q.); (F.J.d.l.M.); (J.S.-N.)
- Institute “Ramón y Cajal” for Health Research (IRYCIS), 28034 Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029 Madrid, Spain
| | - Jorge Pérez-Serrano
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, Spain; (N.G.-C.); (J.S.); (J.P.-S.); (J.L.C.-P.)
| | - Javier Sánchez-Nieves
- Department of Organic and Inorganic Chemistry, Research Institute in Chemistry “Andrés M. del Río” (IQAR), University of Alcalá, 28871 Alcalá de Henares, Spain; (S.Q.); (F.J.d.l.M.); (J.S.-N.)
- Institute “Ramón y Cajal” for Health Research (IRYCIS), 28034 Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28029 Madrid, Spain
| | - José Luis Copa-Patiño
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, Spain; (N.G.-C.); (J.S.); (J.P.-S.); (J.L.C.-P.)
| |
Collapse
|
17
|
Heredero-Bermejo I, Martín-Pérez T, Copa-Patiño JL, Gómez R, de la Mata FJ, Soliveri J, Pérez-Serrano J. Ultrastructural Study of Acanthamoeba polyphaga Trophozoites and Cysts Treated In Vitro with Cationic Carbosilane Dendrimers. Pharmaceutics 2020; 12:pharmaceutics12060565. [PMID: 32570829 PMCID: PMC7356815 DOI: 10.3390/pharmaceutics12060565] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 06/15/2020] [Accepted: 06/16/2020] [Indexed: 11/16/2022] Open
Abstract
Cationic carbosilane dendrimers are branched molecules with antimicrobial properties. Their activity has been tested against Acanthamoeba polyphaga, a causative agent of Acanthamoeba keratitis, a severe ocular disease in humans. A. polyphaga trophozoites and cysts were exposed to different noncytotoxic cationic carbosilane dendrimers with proven antiamoebic activity. The effects of treatment on cell surface and cell ultrastructure were examined by scanning and transmission electron microscopy, respectively. Two of the dendrimers tested induced dramatic alterations of cellular ultrastructure in both trophozoites and cysts, including vacuolization, depletion of cytoplasmic contents, and reduced cell size. Additionally, we observed severe alterations of the plasma membrane with membrane blebbing in trophozoites and disruption in cysts. These alterations were also observed with chlorhexidine, a drug used for treatment of Acanthamoeba keratitis. Our results support that these compounds may target membranes, and their action is critical for parasite integrity.
Collapse
Affiliation(s)
- Irene Heredero-Bermejo
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, Alcalá de Henares, 28805 Madrid, Spain; (T.M.-P.); (J.L.C.-P.); (J.S.); (J.P.-S.)
- Correspondence:
| | - Tania Martín-Pérez
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, Alcalá de Henares, 28805 Madrid, Spain; (T.M.-P.); (J.L.C.-P.); (J.S.); (J.P.-S.)
| | - José Luis Copa-Patiño
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, Alcalá de Henares, 28805 Madrid, Spain; (T.M.-P.); (J.L.C.-P.); (J.S.); (J.P.-S.)
| | - Rafael Gómez
- Department of Organic and Inorganic Chemistry, Research Institute on Chemistry “Andrés M. del Río” (IQAR), University of Alcalá, Alcalá de Henares, 28805 Madrid, Spain; (R.G.); (F.J.d.l.M.)
- Institute “Ramón y Cajal” for Health Research (IRYCIS), 28034 Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) ISCIII, 28029 Madrid, Spain
| | - Francisco Javier de la Mata
- Department of Organic and Inorganic Chemistry, Research Institute on Chemistry “Andrés M. del Río” (IQAR), University of Alcalá, Alcalá de Henares, 28805 Madrid, Spain; (R.G.); (F.J.d.l.M.)
- Institute “Ramón y Cajal” for Health Research (IRYCIS), 28034 Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) ISCIII, 28029 Madrid, Spain
| | - Juan Soliveri
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, Alcalá de Henares, 28805 Madrid, Spain; (T.M.-P.); (J.L.C.-P.); (J.S.); (J.P.-S.)
| | - Jorge Pérez-Serrano
- Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, Alcalá de Henares, 28805 Madrid, Spain; (T.M.-P.); (J.L.C.-P.); (J.S.); (J.P.-S.)
| |
Collapse
|
18
|
Rajak BL, Kumar R, Gogoi M, Patra S. Antimicrobial Activity of Nanomaterials. ENVIRONMENTAL CHEMISTRY FOR A SUSTAINABLE WORLD 2020. [DOI: 10.1007/978-3-030-29207-2_5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/07/2022]
|
19
|
Barrios-Gumiel A, Sanchez-Nieves J, Pérez-Serrano J, Gómez R, de la Mata FJ. PEGylated AgNP covered with cationic carbosilane dendrons to enhance antibacterial and inhibition of biofilm properties. Int J Pharm 2019; 569:118591. [DOI: 10.1016/j.ijpharm.2019.118591] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2019] [Revised: 07/30/2019] [Accepted: 08/01/2019] [Indexed: 10/26/2022]
|
20
|
Martín-Pérez T, Lozano-Cruz T, Criado-Fornelio A, Ortega P, Gómez R, de la Mata FJ, Pérez-Serrano J. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini. Parasitol Res 2019; 118:1953-1961. [PMID: 31069536 DOI: 10.1007/s00436-019-06341-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2018] [Accepted: 04/29/2019] [Indexed: 11/26/2022]
Abstract
The genus Acanthamoeba can cause Acanthamoeba keratitis (AK) and granulomatous amoebic encephalitis (GAE). The treatment of these illnesses is hampered by the existence of a resistance stage that many times causes infection relapses. In an attempt to add new agents to our chemotherapeutic arsenal against acanthamebiasis, two Acanthamoeba isolates were treated in vitro with newly synthesized biguanide dendrimers. Trophozoite viability analysis and ultrastructural studies showed that dendrimers prevent encystment by lysing the cellular membrane of the amoeba. Moreover, one of the dendrimers showed low toxicity when tested on mammalian cell cultures, which suggest that it might be eventually used as an amoebicidal drug or as a disinfection compound in contact lens solutions.
Collapse
Affiliation(s)
- T Martín-Pérez
- Departamento de Biomedicina y Biotecnología, Laboratorio de Parasitología, Grupo ECOMYP, Facultad de Farmacia, Universidad de Alcalá, 28805, Alcalá de Henares, Madrid, Spain.
| | - T Lozano-Cruz
- Instituto de Investigación Química "Andrés M. del Río" (IQAR), Departamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, Campus Universitario, 28805, Alcalá de Henares, Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ctra. Colmenar Viejo, Km. 9100, 28034, Madrid, Spain
| | - A Criado-Fornelio
- Departamento de Biomedicina y Biotecnología, Laboratorio de Parasitología, Grupo ECOMYP, Facultad de Farmacia, Universidad de Alcalá, 28805, Alcalá de Henares, Madrid, Spain
| | - P Ortega
- Instituto de Investigación Química "Andrés M. del Río" (IQAR), Departamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, Campus Universitario, 28805, Alcalá de Henares, Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ctra. Colmenar Viejo, Km. 9100, 28034, Madrid, Spain
| | - R Gómez
- Instituto de Investigación Química "Andrés M. del Río" (IQAR), Departamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, Campus Universitario, 28805, Alcalá de Henares, Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ctra. Colmenar Viejo, Km. 9100, 28034, Madrid, Spain
| | - F J de la Mata
- Instituto de Investigación Química "Andrés M. del Río" (IQAR), Departamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, Campus Universitario, 28805, Alcalá de Henares, Madrid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Málaga, Spain
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Ctra. Colmenar Viejo, Km. 9100, 28034, Madrid, Spain
| | - J Pérez-Serrano
- Departamento de Biomedicina y Biotecnología, Laboratorio de Parasitología, Grupo ECOMYP, Facultad de Farmacia, Universidad de Alcalá, 28805, Alcalá de Henares, Madrid, Spain
| |
Collapse
|
21
|
Carmona-Ribeiro AM. Self-Assembled Antimicrobial Nanomaterials. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2018; 15:E1408. [PMID: 29973521 PMCID: PMC6069395 DOI: 10.3390/ijerph15071408] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/22/2018] [Revised: 06/28/2018] [Accepted: 06/29/2018] [Indexed: 12/17/2022]
Abstract
Nanotechnology came to stay improving the quality of human life by reducing environmental contamination of earth and water with pathogens. This review discusses how self-assembled antimicrobial nanomaterials can contribute to maintain humans, their water and their environment inside safe boundaries to human life even though some of these nanomaterials display an overt toxicity. At the core of their strategic use, the self-assembled antimicrobial nanomaterials exhibit optimal and biomimetic organization leading to activity at low doses of their toxic components. Antimicrobial bilayer fragments, bilayer-covered or multilayered nanoparticles, functionalized inorganic or organic polymeric materials, coatings and hydrogels disclose their potential for environmental and public health applications in this review.
Collapse
Affiliation(s)
- Ana Maria Carmona-Ribeiro
- Biocolloids Laboratory, Instituto de Química, Universidade de São Paulo; Av. Prof. Lineu Prestes 748, São Paulo 05508-000, Brazil.
| |
Collapse
|